Filing Details
- Accession Number:
- 0001069530-22-000037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-16 16:28:05
- Reporting Period:
- 2022-08-12
- Accepted Time:
- 2022-08-16 16:28:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1069530 | Cassava Sciences Inc | SAVA | Pharmaceutical Preparations (2834) | 911911336 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1532303 | Eric Schoen | C/O Cassava Sciences, Inc. 7801 N. Capital Of Texas Hwy.; Suite 260 Austin TX 78731 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-08-12 | 2,500 | $19.95 | 19,800 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,000 | Indirect | By limited liability corporation |
Footnotes
- Represents open market purchase of common stock for cash